Average cost per year*
Average cost per beneficiary*
Ciclesonide is used to prevent and reduce the symptoms (wheezing and shortness of breath) caused by asthma. Controlling asthma symptoms may decrease time lost from work or school. This medication belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. This medication must be taken regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler as prescribed. Keep track of how often you need to use your quick-relief inhaler, and tell your doctor. If your quick-relief inhaler does not seem to work as well, if you need to use more than usual of your quick-relief inhaler for 2 or more days in a row, or if you need to use more than one full canister of your quick-relief inhaler over a 2-month period, seek immediate medical attention. NOTE: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
*Origin of the terms and chart data used within this page: https://data.cms.gov/
Yes, Alvesco is covered by Medicare.
In 2021, the average cost per dose of Alvesco was $12.06.
The average dose of Alvesco received per year is 1,415,964 units
79,758 Medicare beneficiaries received Alvesco in 2021, which was a -0.05% from 2020
There were 207,443 claims made by Medicare beneficiaries, which is a -0.05% from 2020
The average spending amount per claim in 2021 was $154.14
The average Medicare spending per beneficiary amount for Alvesco was $400.89
Covis Pharma received $31,974,256.19
The total amount spent on Alvesco by Medicare is $31,974,256.19
Short Term Medical Insurance
Limited Fixed Indemnity Plans